Amylosulfuric Acid

Amylosulfuric Acid

SCHEMBL1531835

CCCCCOS(=O)(=O)[O-].[H+]

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.87
TSHR P16473 2/20 0.87
GLA P06280 1/20 0.87
HPGD P15428 1/20 0.87
MAPK1 P28482 1/20 0.87
EPHX2 P34913 1/20 0.87
BLM P54132 1/20 0.87
CA1 P00915 12/20 0.58
CA2 P00918 12/20 0.58
CA9 Q16790 10/20 0.58
CA12 O43570 3/20 0.56
CA7 P43166 3/20 0.56
CA14 Q9ULX7 3/20 0.56
CA3 P07451 2/20 0.56
CA4 P22748 2/20 0.56
CA6 P23280 2/20 0.56
CA5A P35218 2/20 0.56
CA5B Q9Y2D0 2/20 0.56
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11173505 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL3271081 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL11372853 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL11046781 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL10685394 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
SCHEMBL11371614 0.98 RECQL (0.91) RECQLTSHRGLAHPGDMAPK1
Amylosulfuric Acid SCHEMBL900199 0.95 RECQL (0.87) RECQLTSHRGLAHPGDMAPK1
Amylosulfuric Acid SCHEMBL2544572 0.95 RECQL (0.87) RECQLTSHRGLAHPGDMAPK1
Amylosulfuric Acid SCHEMBL1134661 0.95 RECQL (0.95) RECQLTSHRGLAHPGDMAPK1
Amylosulfuric Acid SCHEMBL9950149 0.95 RECQL (0.87) RECQLTSHRGLAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2483471-A2 ELECTROSTATIC CHARGE DISSIPATIVE MATERIALS OBTAINED BY VACUUM DEPOSITION OF MONOMERS AND POLYMERIZATION E. I. du Pont de Nemours and Company (US) 2012-08-08 EP claimed
US-20110244745-A1 ELECTROSTATIC CHARGE DISSIPATIVE MATERIALS BY VACUUM DEPOSITION OF POLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-10-06 US claimed
WO-2011037826-A2 ELECTROSTATIC CHARGE DISSIPATIVE MATERIALS BY VACUUM DEPOSITION OF POLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-03-31 WO claimed
US-11292853-B2 Methods and compositions for curing a surface of an uncured polysulfide rubber THE BOEING COMPANY (US) 2022-04-05 US disclosed
EP-3753973-A1 A METHOD FOR SEALING A GAP BETWEEN ADJOINING OR CONNECTED SOLID SURFACES ON AN AIRCRAFT The Boeing Company (US) 2020-12-23 EP disclosed
EP-3431528-B1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER BOEING CO (US) 2020-09-02 EP disclosed
US-20200190226-A1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER THE BOEING COMPANY 2020-06-18 US disclosed
US-10597468-B2 Methods and compositions for curing a surface of an uncured polysulfide rubber THE BOEING COMPANY (US) 2020-03-24 US disclosed
US-20190023814-A1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER THE BOEING COMPANY 2019-01-24 US disclosed
EP-3431528-A1 METHODS AND COMPOSITIONS FOR CURING A SURFACE OF AN UNCURED POLYSULFIDE RUBBER The Boeing Company (US) 2019-01-23 EP disclosed
EP-2680821-B1 LIPOSOME FORMULATION COMPRISING AN ANTI-TUMOUR ACTIVE SUBSTANCE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING IT WROCLAWSKIE CENTRUM BADAN EIT SP Z O O (PL) 2018-08-01 EP disclosed
EP-2493904-A1 N-SUBSTITUTED ACRYLAMIDES, PREPARATION METHOD AND USE THEREOF Rhodia (China) Co., Ltd. (CN) 2012-09-05 EP disclosed
US-20120202958-A1 N-SUBSTITUTED ACRYLAMIDES, PREPARATION METHOD AND USE THEREOF SOLVAY (CHINA) CO., LTD. (CN) 2012-08-09 US disclosed
EP-2483471-A2 ELECTROSTATIC CHARGE DISSIPATIVE MATERIALS OBTAINED BY VACUUM DEPOSITION OF MONOMERS AND POLYMERIZATION E. I. du Pont de Nemours and Company (US) 2012-08-08 EP disclosed
US-20110244745-A1 ELECTROSTATIC CHARGE DISSIPATIVE MATERIALS BY VACUUM DEPOSITION OF POLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-10-06 US disclosed
WO-2011050534-A1 N-SUBSTITUTED ACRYLAMIDES, PREPARATION METHOD AND USE THEREOF RHODIA (CHINA) CO., LTD. (CN) 2011-05-05 WO disclosed
WO-2011037826-A2 ELECTROSTATIC CHARGE DISSIPATIVE MATERIALS BY VACUUM DEPOSITION OF POLYMERS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2011-03-31 WO disclosed
US-5792828-A Dry blending of acrylamidoalkanesulfonic acid monomer with basic compounds THE LUBRIZOL CORPORATION (US) 1998-08-11 US disclosed
EP-0841322-A1 Dry blending of acrylamidoalkanesulfonic acid monomer with basic compounds The Lubrizol Corporation (US) 1998-05-13 EP disclosed
US-4008293-A ACRYLIC COPOLYMER, AMINOPLAST, BINDER PPG INDUSTRIES, INC. (US) 1977-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202958-A1 N-SUBSTITUTED ACRYLAMIDES, PREPARATION METHOD AND USE THEREOF RAD54L, MASTL, ALK RECQL 71/4885TSHR 829/4885GLA 3782/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.